Guanfacine NDC 27241-242

NDC codes

FDA NDC Directory

Product NDC (as listed)27241-242Labeler and product segments. Claims need a package NDC.

Product NDC at billing width27241-0242Add the package segment from the table below.

Package NDCs as listed with the FDA, and the 11-digit 5-4-2 form used on claims. The highlighted digit is the added leading zero.
Package NDC	11-digit (billing)	Package	Copy
27241-242-01	27241024201	100 TABLET in 1 BOTTLE (27241-242-01)Marketed from Apr 27, 2023

How the 11-digit form is made: The product segment has 3 digits, so one leading zero is added to it (5-3-2 → 5-4-2). Formatting the NDC does not by itself make it billable — the product, package and quantity must match what was dispensed or administered, and payer rules apply. Conversion rules

Product information

Brand name (proprietary): Guanfacine
Generic name (nonproprietary): guanfacine
Active ingredients: Guanfacine hydrochloride — 1 mg/1
Dosage form: Tablet
Route: Oral
Labeler: Ajanta Pharma USA Inc.
Product type: Prescription drug
Marketing category: ANDA — Abbreviated New Drug Application (generic)Application ANDA 217293
Marketing start: Apr 27, 2023
Listing expires: Dec 31, 2027
Other FDA classes: Adrenergic alpha2-Agonists (Mechanism)
Identifiers: Product ID 27241-242_de4816b4-f03b-4b28-ac3d-979c166b4c9cSPL ID de4816b4-f03b-4b28-ac3d-979c166b4c9cSPL set ID 830c0be8-2137-46ee-94c6-aa048b7de35fRxCUI 197745, 197746UNII PML56A160OUPC 0327241243011, 0327241242014
Pharmacologic class: Central alpha-2 Adrenergic Agonist

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No HCPCS code in Med-Code's directory. Oral products like this are usually dispensed by a pharmacy and billed by NDC.

NDC on a medical claim

N427241024201 followed by a unit qualifier and the quantity

Package 27241-0242-01. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Current FDA label (SPL), effective Nov 5, 2025.

Indications (excerpt from the label)

INDICATIONS AND USAGE Guanfacine tablets, USP are indicated in the management of hypertension. Guanfacine tablets, USP may be given alone or in combination with other antihypertensive agents, especially thiazide-type diuretics.

Excerpt only. Read the full label for complete information.

Full label on DailyMed (opens in a new tab)

Other NDCs under ANDA 217293

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.

FDA NDC Directory listings under ANDA 217293
Product	Strength	Form · route	Labeler	Product NDC
Guanfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	Coupler LLC	67046-1655
Guanfacine	Guanfacine hydrochloride 1 mg/1	TabletOral	Coupler LLC	67046-1433
Guanfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	REMEDYREPACK INC.	70518-4488
Guanfacine	Guanfacine hydrochloride 2 mg/1	TabletOral	Ajanta Pharma USA Inc.	27241-243
Guanfacine	Guanfacine hydrochloride 1 mg/1	TabletOral	REMEDYREPACK INC.	70518-4333